Litcius/Paper detail

TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer

Zhong Tian, Jing Zhang, Xingren Liu, Hongmin Li

2023Cellular Oncology17 citationsDOIOpen Access PDF

Topics & Concepts

CisplatinDownregulation and upregulationGene knockdownUbiquitin ligaseCancer researchUbiquitinLung cancerChemotherapyIn vivoCellCell cultureChemistryBiologyMedicineOncologyBiochemistryGeneGeneticsBiotechnologyLung Cancer Research StudiesCancer Mechanisms and TherapyPeptidase Inhibition and Analysis
TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer | Litcius